Published in Cardiovascular Device Liability Week, February 3rd, 2008
Vytorin is the combination of Zetia and Zocor, a statin now available as a generic drug for about one-third of the cost.
The investigation centers around charges that the companies have known since 2006 that the combination of drugs was no more effective than the generic version of Zocor in blocking the fatty arterial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.